BioCentury
ARTICLE | Company News

Two more alliances for Elan

February 15, 2000 8:00 AM UTC

Athersys (Cleveland, Ohio) and ELN formed a joint venture to develop a protein to treat AIDS-related muscle wasting. The venture will combine Athersys' Random Activation of Gene Expression (RAGE) technology with ELN's Medipad drug delivery system. ELN made an equity investment in Athersys. ...